Ethiopathogenesis, diagnosis and prevention of vascular calcification in end stage renal disease

Emiliana Ferramosca1, Antonio Bellasi, Carlo Ratti

  • 1Tulane University School of Medicine, 1430 Tulane Avenue, SL-48, New Orleans, LA, 70112, USA.

Current Medicinal Chemistry. Cardiovascular and Hematological Agents
|April 28, 2005
PubMed

Insights

Vascular calcification and atherosclerosis are common in end-stage renal disease (ESRD), driven by metabolic issues and inflammation. This process is a regulated, bone-like mineralization, not just passive crystal deposition.

Area of Science:

  • Nephrology
  • Cardiovascular Medicine
  • Pathology

Background:

  • End-stage renal disease (ESRD) patients exhibit high rates of atherosclerosis and vascular calcification, contributing to cardiovascular disease.
  • Traditional risk factors inadequately explain the elevated cardiovascular disease incidence in ESRD.
  • Vascular calcification in ESRD involves both intimal and medial layers, with distinct cellular and pathological characteristics.

Purpose of the Study:

  • To review the etiopathogenesis of vascular calcification in ESRD.
  • To discuss modern imaging modalities for detecting vascular calcification.
  • To outline current therapeutic strategies for managing vascular calcification progression in ESRD.

Main Methods:

  • Literature review focusing on the pathophysiology of vascular calcification in ESRD.
  • Analysis of studies on imaging techniques for vascular calcification detection.
  • Synthesis of information on therapeutic interventions for ESRD-related vascular calcification.

Main Results:

  • Vascular calcification in ESRD is a complex, regulated process involving vascular smooth muscle cell (VSMC) phenotype changes and bone metabolism proteins.
  • Metabolic abnormalities (calcium-phosphate) and inflammation in ESRD are key contributors to vascular calcification.
  • Vascular calcification is not merely passive hydroxyapatite deposition but an active, biologically regulated phenomenon.

Conclusions:

  • Vascular calcification in ESRD is a regulated, active process resembling bone formation, influenced by uremic metabolic and inflammatory states.
  • Early detection and targeted therapies are crucial for managing cardiovascular risk in ESRD patients.
  • Understanding the molecular mechanisms of vascular calcification is essential for developing novel treatments.

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Urinary Tract Calculi IV: Nutrition Therapy and Prevention01:27

Urinary Tract Calculi IV: Nutrition Therapy and Prevention

Management of renal calculi focuses on effective strategies like tailored nutrition and hydration therapy. Adjusting diet and fluid intake reduces stone formation and recurrence, making these interventions simple yet powerful in kidney stone prevention and management.Understanding Kidney StonesKidney stones form when calcium, oxalate, uric acid, and cystine concentrate and crystallize in urine. Factors contributing to their formation include genetic predisposition, certain medical conditions,...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Urinary Tract Calculi I: Introduction01:28

Urinary Tract Calculi I: Introduction

Renal calculi, or kidney stones, are solid deposits of minerals and salts formed inside the kidneys. In medical terminology, "calculus" refers to the stone itself, while "lithiasis" describes the process of stone formation. Depending on their location within the urinary system, these stones may be classified as either urolithiasis, when situated within the urinary tract, or nephrolithiasis, when located within the kidneys. Each term signifies the specific impact of the stone.Predisposition...